Paulo Caleb Júnior Lima Santos

SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia

Paulo Caleb Júnior Lima Santos, Ana Carolina Moron Gagliardi, Márcio H. Miname et al. · European Journal of Clinical Pharmacology · 2011 · 68 citations

Lipid Disorder, Cardiovascular Disease, Diabetes +9

Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia

Paulo Caleb Júnior Lima Santos, Aline Morgan Alvarenga, Cintia Elin Jannes et al. · Atherosclerosis · 2014 · 66 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +11

Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population

Rafael de Oliveira Alvim, Paulo Caleb Júnior Lima Santos, Mariane Manso Musso et al. · Diabetology & Metabolic Syndrome · 2013 · 66 citations · Full text

Development of a Pharmacogenetic-Based Warfarin Dosing Algorithm and its Performance in Brazilian Patients: Highlighting the Importance of Population-Specific Calibration

Paulo Caleb Júnior Lima Santos, Leiliane Rodrigues Marcatto, Núbia E. Duarte et al. · Pharmacogenomics · 2015 · 42 citations · Full text

CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation

Paulo Caleb Júnior Lima Santos, Carla Luana Dinardo, Isolmar Tadeu Schettert et al. · European Journal of Clinical Pharmacology · 2012 · 35 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +7